Friday, August 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Market Update Willdan Group Soars Grifols Integration Update Amylyx Pharmaceuticals Trials Disappoint

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
Financing and finances
0
SHARES
22
VIEWS
Share on FacebookShare on Twitter

Exciting Updates for March 8th:

Willdan Group (WLDN): Shares of Willdan Group surged by 21% today after revealing impressive Q4 financial results and providing guidance for FY24 that exceeded expectations. The company also announced a lucrative contract worth $30-50 million spanning three years.

Grifols (GRFS): Grifols clarified that the integration discussed in the 2023 financial statements has no impact on the income statement or key metrics.

Amylyx Pharmaceuticals (AMLYX): Unfortunately, Amylyx Pharmaceuticals shared disappointing news that the PHOENIX Phase 3 trial for AMX0035 in treating Amyotrophic Lateral Sclerosis did not meet its primary endpoint. As a result, their shares plummeted by 81%.

WLDN Stock Performance on March 8, 2024: Pre-Market Surge Indicates Positive News Ahead

On March 8, 2024, the stock performance of WLDN, also known as Willdan Group, Inc., showed some interesting movements. According to data from CNN Money, WLDN is currently trading in the middle of its 52-week range and near its 200-day simple moving average.

The price of WLDN shares experienced a slight decrease of $0.06 since the market last closed, representing a 0.30% drop. The stock closed at $19.85 on the previous trading day. However, in pre-market trading, the stock has since risen by $4.14, indicating a significant increase in value.

This jump in pre-market trading suggests that there may be some positive news or developments surrounding WLDN that are driving investor interest and causing the stock price to rise. Investors will be keeping a close eye on how the stock performs throughout the trading day to see if this momentum continues or if there are any fluctuations.

Willdan Group, Inc. (WLDN) Stock Performance Analysis: Strong Growth in Net Income and EPS

On March 8, 2024, the stock performance of Willdan Group, Inc. (WLDN) showed promising results based on the financial data provided by CNN Money. The company reported a total revenue of $510.10 million for the past year, which represents an 18.87% increase compared to the previous year. However, the total revenue remained flat at $155.68 million for the last quarter.

In terms of net income, Willdan Group, Inc. reported a net income of $10.93 million for the past year, marking a significant increase of 229.33% compared to the previous year. Similar to the total revenue, the net income held flat at $8.03 million for the last quarter.

The earnings per share (EPS) for Willdan Group, Inc. also showed positive growth. The company reported an EPS of $0.80 for the past year, which represents a 223.23% increase compared to the previous year. Additionally, the EPS increased by 407.88% since the last quarter, reaching $0.58.

Overall, the financial performance of Willdan Group, Inc. on March 8, 2024, indicates strong growth in net income and EPS. Investors may find these results encouraging and may consider the company as a potential investment opportunity. It is important to conduct further research and analysis before making any investment decisions based on this information.

Tags: WLDN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Market Today (1)

Analysts Upbeat on Regenxbios Future Prospects

Finance_Business (2)

Financial Expert Downgrades Runway Growth Finance Corp from Overweight to Neutral

Biopharmaceutical Stock Market Today (1)

FDA Requests Further Information on Donanemab Delays Decision Timeline

Recommended

Palantir Stock

Palantir Shares Face Valuation Pressures Despite Strong Earnings

9 months ago
BridgeBio Pharma Stock

BridgeBio Pharma Investors Await Critical Heart Drug Data

9 months ago
Ocugen Stock

Ocugen’s Fresh $130M Cushion Sets the Stage for a Data-Heavy July and a Pivotal Regulatory Filing

1 month ago
Airbnb Stock

Navigating Regulatory Headwinds and Innovation: Airbnb’s Strategic Crossroads

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

MSCI World ETF: Index Provider Rewrites the Rulebook for Fast-Moving Stocks

Airbus’ Paradox: A Slightly Smaller Forecast That Nobody Seems to Mind

Almonty Industries Rebounds From Index-Driven Exit as Tungsten Calculus Shifts Westward

OHB’s Two-Faced Half-Year: Record Orders Mask a Profit Squeeze That Spooked the Market

Trending

Nel ASA Stock
Analysis

Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding

by Jackson Burston
August 7, 2026
0

The Norwegian electrolyser maker Nel ASA is living a split-screen reality. Its order intake just exploded by...

SANDISK Stock

SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market

August 7, 2026
Bitcoin Stock

Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

August 7, 2026
Kioxia Stock

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

August 7, 2026
FALLBACK Stock

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

August 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding
  • SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market
  • Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com